These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32383480)

  • 1. Harnessing proteases for T regulatory cell immunotherapy.
    Amarnath S; Brown ML
    Eur J Immunol; 2020 Jun; 50(6):770-778. PubMed ID: 32383480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple in vitro generation of human leukocyte antigen-G-expressing T-regulatory cells through pharmacological hypomethylation for adoptive cellular immunotherapy against graft-versus-host disease.
    Stamou P; Marioli D; Patmanidi AL; Sgourou A; Vittoraki A; Theofani E; Pierides C; Taraviras S; Costeas PA; Spyridonidis A
    Cytotherapy; 2017 Apr; 19(4):521-530. PubMed ID: 28162915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Levels of Tl1a Affect the Expansion and Function of Regulatory T Cells in Modulating Murine Colitis.
    Sidhu-Varma M; Shih DQ; Targan SR
    Inflamm Bowel Dis; 2016 Mar; 22(3):548-59. PubMed ID: 26818423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human LAP
    Wang H; Song H; Pham AV; Cooper LJ; Schulze JJ; Olek S; Tran DQ
    Theranostics; 2019; 9(8):2315-2324. PubMed ID: 31149046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
    Elinav E; Waks T; Eshhar Z
    Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of murine and human Treg subsets in inflammatory bowel disease.
    Sun X; He S; Lv C; Sun X; Wang J; Zheng W; Wang D
    Mol Med Rep; 2017 Sep; 16(3):2893-2898. PubMed ID: 28677759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient local depletion of Foxp3+ regulatory T cells during recovery from colitis via Fas/Fas ligand-induced death.
    Reardon C; Wang A; McKay DM
    J Immunol; 2008 Jun; 180(12):8316-26. PubMed ID: 18523298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of naturally arising regulatory T cells in hematopoietic cell transplantation.
    Nguyen VH; Zeiser R; Negrin RS
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):995-1009. PubMed ID: 17084366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host Disease.
    Velaga S; Ukena SN; Dringenberg U; Alter C; Pardo J; Kershaw O; Franzke A
    PLoS One; 2015; 10(4):e0124927. PubMed ID: 25928296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of TNF-α on Regulatory T Cell Function in Graft-versus-Host Disease.
    Mancusi A; Piccinelli S; Velardi A; Pierini A
    Front Immunol; 2018; 9():356. PubMed ID: 29541073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
    Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
    J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy.
    Dees S; Ganesan R; Singh S; Grewal IS
    Eur J Immunol; 2021 Feb; 51(2):280-291. PubMed ID: 33302322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-bound Dickkopf-1 in Foxp3
    Chae WJ; Park JH; Henegariu O; Yilmaz S; Hao L; Bothwell ALM
    Immunology; 2017 Oct; 152(2):265-275. PubMed ID: 28556921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis.
    Di Giovangiulio M; Rizzo A; Franzè E; Caprioli F; Facciotti F; Onali S; Favale A; Stolfi C; Fehling HJ; Monteleone G; Fantini MC
    Front Immunol; 2019; 10():2158. PubMed ID: 31572375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting immune responses by LIGHT in the face of abundant regulatory T cell inhibition.
    Wang Y; Zhu M; Yu P; Fu YX
    J Immunol; 2010 Feb; 184(3):1589-95. PubMed ID: 20042587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells.
    Hernandez AL; Kitz A; Wu C; Lowther DE; Rodriguez DM; Vudattu N; Deng S; Herold KC; Kuchroo VK; Kleinewietfeld M; Hafler DA
    J Clin Invest; 2015 Nov; 125(11):4212-22. PubMed ID: 26524592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic-T-lymphocyte-associated antigen 4 blockade abrogates protection by regulatory T cells in a mouse model of microbially induced innate immune-driven colitis.
    Watanabe K; Rao VP; Poutahidis T; Rickman BH; Ohtani M; Xu S; Rogers AB; Ge Z; Horwitz BH; Fujioka T; Erdman SE; Fox JG
    Infect Immun; 2008 Dec; 76(12):5834-42. PubMed ID: 18824539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
    Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
    J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promise of CD4
    Copsel S; Wolf D; Komanduri KV; Levy RB
    Haematologica; 2019 Jul; 104(7):1309-1321. PubMed ID: 31221786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.